Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation-Reference-Cited by-同舟云学术

Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation

Published:1999-10-15 Issue:22 Volume:42 Page:4669-4679
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Jung Manfred¹,Brosch Gerald¹,Kölle Doris¹,Scherf Hans¹,Gerhäuser Clarissa¹,Loidl Peter¹

Affiliation:

1. Institut für Pharmazeutische Chemie, Westfälische Wilhelms-Universität Münster, Hittorfstrasse 58-62, 48149 Münster, Germany, Department of Microbiology, University of Innsbruck, Medical School, Fritz-Pregl-Strasse 3, 6020 Innsbruck, Austria, and German Cancer Research Center, Division C0200, Toxicology and Cancer Risk Factors, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm991091h

Reference27 articles.

1. Histone acetylation: facts and questions

2. Identification of Maize Histone Deacetylase HD2 as an Acidic Nucleolar Phosphoprotein

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase;Molecules;2024-01-01

2. Cu-Catalyzed α-Alkylation of Glycine Derivatives for C(sp³)–H/C(sp³)–H Bond Selective Functionalization;ACS Catalysis;2023-12-22

3. Oxidation/Alkylation of Amino Acids with α-Bromo Carbonyls Catalyzed by Copper and Quick Access to HDAC Inhibitor;The Journal of Organic Chemistry;2023-12-01

4. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-08-24

5. Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds;Pharmaceuticals;2023-07-06